StockData
Pharma-Bio Serv, Inc. logo

Pharma-Bio Serv, Inc. (PBSV) stock

PBSVOTCServices-Management Consulting ServicesFiscal year ends October 31
Financials through Q3 FY2026, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 14, 2026Score 9/30
$0.48+0.08 (+20.00%)

Close on Oct 19, 2026Market cap $11.00MP/E 48.0Yield –

Pharma-Bio Serv profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Pharma-Bio Serv's profit margin for the twelve months ending Jul 31, 2026 was 2.7%. For fiscal 2025 it was -1.1%, against -8.2% the year before. The highest annual figure on record is 16.0% in fiscal 2012.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Oct 31, 2025-1.1%+7.1
FY2024Oct 31, 2024-8.2%−15.9
FY2023Oct 31, 20237.7%+2.5
FY2022Oct 31, 20225.2%+15.6
FY2021Oct 31, 2021-10.4%−19.9
FY2020Oct 31, 20209.5%−1.2
FY2019Oct 31, 201910.7%+3.5
FY2018Oct 31, 20187.2%+17.8
FY2017Oct 31, 2017-10.6%−9.3
FY2016Oct 31, 2016-1.3%−8.3
FY2015Oct 31, 20156.9%−1.8
FY2014Oct 31, 20148.8%−6.1
FY2013Oct 31, 201314.8%−1.2
FY2012Oct 31, 201216.0%+0.2
FY2011Oct 31, 201115.8%+12.6
FY2010Oct 31, 20103.3%–

Quarterly profit margin

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange (pts)
Q3 FY2026CQ2 2026Jul 31, 2026-0.6%+9.8
Q2 FY2026CQ1 2026Apr 30, 20268.6%+4.7
Q1 FY2026CQ4 2025Jan 31, 20261.4%+1.1
Q4 FY2025CQ3 2025Oct 31, 2025-0.0%−0.7
Q3 FY2025CQ2 2025Jul 31, 2025-10.4%+2.4
Q2 FY2025CQ1 2025Apr 30, 20253.9%+12.9
Q1 FY2025CQ4 2024Jan 31, 20250.3%+11.7
Q4 FY2024CQ3 2024Oct 31, 20240.7%+2.0
Q3 FY2024CQ2 2024Jul 31, 2024-12.8%−24.3
Q2 FY2024CQ1 2024Apr 30, 2024-9.0%−17.9
Q1 FY2024CQ4 2023Jan 31, 2024-11.4%−21.4
Q4 FY2023CQ3 2023Oct 31, 2023-1.3%−7.0
Q3 FY2023CQ2 2023Jul 31, 202311.5%+98.6
Q2 FY2023CQ1 2023Apr 30, 20238.9%−36.7
Q1 FY2023CQ4 2022Jan 31, 202310.1%+5.3
Q1 FY2022CQ4 2021Jul 31, 20225.6%−0.3
Q4 FY2021CQ3 2021Oct 31, 2021-87.1%−89.9
Q3 FY2021CQ2 2021Jul 31, 202145.6%+34.6
Q2 FY2021CQ1 2021Apr 30, 20214.8%−7.4
Q1 FY2021CQ4 2020Jan 31, 20216.0%−5.4
Q4 FY2020CQ3 2020Oct 31, 20202.9%−7.0
Q3 FY2020CQ2 2020Jul 31, 202011.0%+2.3
Q2 FY2020CQ1 2020Apr 30, 202012.2%−1.6
Q1 FY2020CQ4 2019Jan 31, 202011.4%+1.1
Q4 FY2019CQ3 2019Oct 31, 20199.9%−49.0
Q3 FY2019CQ2 2019Jul 31, 20198.7%−7.1
Q2 FY2019CQ1 2019Apr 30, 201913.7%+17.1
Q1 FY2019CQ4 2018Jan 31, 201910.3%+81.8
Q4 FY2018CQ3 2018Oct 31, 201858.9%+99.4
Q3 FY2018CQ2 2018Jul 31, 201815.8%+19.9
Q2 FY2018CQ1 2018Apr 30, 2018-3.4%+4.8
Q1 FY2018CQ4 2017Jan 31, 2018-71.5%−62.0
Q4 FY2017CQ3 2017Oct 31, 2017-40.5%−29.5
Q3 FY2017CQ2 2017Jul 31, 2017-4.1%−1.4
Q2 FY2017CQ1 2017Apr 30, 2017-8.2%–
Q1 FY2017CQ4 2016Jan 31, 2017-9.4%–
Q4 FY2016CQ3 2016Oct 31, 2016-11.1%–
Q3 FY2016CQ2 2016Jul 31, 2016-2.7%–

More Pharma-Bio Serv figures

See a number that looks wrong?